247: Vertex vs. insurers, Moderna's future, & biotech's long winter
b'STAT\\u2019s Ed Silverman joins us to explain how an escalating fight between Vertex Pharmaceuticals and insurance companies has left patients and families caught in the middle. We also discuss the latest news in the life sciences, including the demise of a one-time unicorn, Moderna\\u2019s difficult second act, and an official biotech presidential run.'